HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections.

AbstractBACKGROUND:
Coagulase-negative Staphylococcus epidermidis has become a major frequent cause of infections in relation to the use of implanted medical devices. The pathogenicity of S. epidermidis has been attributed to its capacity to form biofilms on surfaces of medical devices, which greatly increases its resistance to many conventional antibiotics and often results in chronic infection. It has an urgent need to design novel antibiotics against staphylococci infections, especially those can kill cells embedded in biofilm.
RESULTS:
In this report, a series of novel inhibitors of the histidine kinase (HK) YycG protein of S. epidermidis were discovered first using structure-based virtual screening (SBVS) from a small molecular lead-compound library, followed by experimental validation. Of the 76 candidates derived by SBVS targeting of the homolog model of the YycG HATPase_c domain of S. epidermidis, seven compounds displayed significant activity in inhibiting S. epidermidis growth. Furthermore, five of them displayed bactericidal effects on both planktonic and biofilm cells of S. epidermidis. Except for one, the compounds were found to bind to the YycG protein and to inhibit its auto-phosphorylation in vitro, indicating that they are potential inhibitors of the YycG/YycF two-component system (TCS), which is essential in S. epidermidis. Importantly, all these compounds did not affect the stability of mammalian cells nor hemolytic activities at the concentrations used in our study.
CONCLUSION:
These novel inhibitors of YycG histidine kinase thus are of potential value as leads for developing new antibiotics against infecting staphylococci. The structure-based virtual screening (SBVS) technology can be widely used in screening potential inhibitors of other bacterial TCSs, since it is more rapid and efficacious than traditional screening technology.
AuthorsZhiqiang Qin, Jian Zhang, Bin Xu, Lili Chen, Yang Wu, Xiaomei Yang, Xu Shen, Soeren Molin, Antoine Danchin, Hualiang Jiang, Di Qu
JournalBMC microbiology (BMC Microbiol) Vol. 6 Pg. 96 (Nov 10 2006) ISSN: 1471-2180 [Electronic] England
PMID17094812 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Protein Kinase Inhibitors
  • Protein Kinases
  • Histidine Kinase
  • YycG protein, Staphylococcus epidermidis
Topics
  • Amino Acid Sequence
  • Animals
  • Anti-Bacterial Agents (chemistry, metabolism, pharmacology)
  • Bacterial Proteins (antagonists & inhibitors, genetics, metabolism)
  • Binding Sites
  • Biofilms (drug effects)
  • Cell Survival (drug effects)
  • Chlorocebus aethiops
  • Dose-Response Relationship, Drug
  • Hemolysis (drug effects)
  • Histidine Kinase
  • Humans
  • Models, Biological
  • Models, Molecular
  • Molecular Sequence Data
  • Molecular Structure
  • Protein Binding
  • Protein Kinase Inhibitors (chemistry, metabolism, pharmacology)
  • Protein Kinases (chemistry, genetics, metabolism)
  • Protein Structure, Secondary
  • Protein Structure, Tertiary
  • Sequence Homology, Amino Acid
  • Staphylococcal Infections (microbiology, prevention & control)
  • Staphylococcus epidermidis (drug effects, enzymology, growth & development)
  • Structure-Activity Relationship
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: